Intraoperative Ipsilateral Subclavian Port Catheter Implantation in Resectable Breast Cancer Patients: A Novel, Safe, and Convenient Clinical Practice

Overview

Journal Cancer Med

Specialty Oncology

Date 2020 Nov 4

PMID 33145946

Authors

Feng Ye

Yubo Liu

Ping Yu

Na Li

Yan Wang

Xiaoming Xie

Jun Tang

Affiliations

Soon will be listed here.

Abstract

Background: Port catheter (PC) is a classical route of administering chemotherapy for breast cancer patients. We established a standard operating procedure (SOP) of intraoperative ipsilateral subclavian PC implantation in selected resectable breast cancer patients.

Methods: We conducted a prospective clinical study to assess its safety and complications. A total of seventy six resectable breast cancer patients were included for intraoperative ipsilateral subclavian PC implantation. Thirty patients receiving conventional percutaneous contralateral PC implantation under local anesthesia at the same period were recruited as control group. The time consuming of implantation, and PC-related complications were recorded. Visual analog scale questionnaires were used to assess patients' satisfaction.

Results: Compared with conventional contralateral PC implantation under local anesthesia, SOP for intraoperative ipsilateral subclavian PC implantation significantly shortens the time consuming (11.6 vs. 28.6 min, p < 0.001). With a median retention time of 6.3 months, the overall incidence rate of PC-related complications is 21%, of which the most common complications are infections and venous thromboembolism (7.9% for each). Most patients (86.8%) with intraoperative ipsilateral subclavian PC implantation have completed the whole chemotherapy successfully. Due to the general anesthesia and shorter time consuming, intraoperative implantation gains significantly more patients' satisfaction.

Conclusions: In the present study, we develop a SOP for intraoperative ipsilateral subclavian PC implantation in resectable breast cancer patients, which is noval, convenient, and safe. In selected breast cancer patients with indications for adjuvant chemotherapy, this practice could significantly shorten the time consuming of PC implantation and improve the degree of patients' satisfaction.

References

van Loon F, Puijn L, van Aarle W, Dierick-van Daele A, Bouwman A . Pain upon inserting a peripheral intravenous catheter: Size does not matter. J Vasc Access. 2018; 19(3):258-265. DOI: 10.1177/1129729817747531. View

Pinelli F, Cecero E, DeglInnocenti D, Selmi V, Giua R, Villa G . Infection of totally implantable venous access devices: A review of the literature. J Vasc Access. 2018; 19(3):230-242. DOI: 10.1177/1129729818758999. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1):7-30. DOI: 10.3322/caac.21590. View

Tan L, Sun Y, Zhu L, Lei X, Liang D, Rao N . Risk factors of catheter-related thrombosis in early-stage breast cancer patients: a single-center retrospective study. Cancer Manag Res. 2019; 11:8379-8389. PMC: 6750851. DOI: 10.2147/CMAR.S212375. View

Taxbro K, Hammarskjold F, Thelin B, Lewin F, Hagman H, Hanberger H . Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial. Br J Anaesth. 2019; 122(6):734-741. DOI: 10.1016/j.bja.2019.01.038. View

Poorvu P, Winer E . Adjuvant Chemotherapy for ER+ Breast Cancer: A Sea Change is Underway. J Natl Cancer Inst. 2017; 110(5):443-445. DOI: 10.1093/jnci/djx264. View

El-Balat A, Schmeil I, Karn T, Holtrich U, Mavrova-Risteska L, Rody A . Catheter-related Complications of Subcutaneous Implantable Venous Access Devices in Breast Cancer Patients. In Vivo. 2018; 32(5):1275-1281. PMC: 6199593. DOI: 10.21873/invivo.11377. View

Nas O, Hacikurt K, Kaya A, Dogan N, Sanal B, Ozkaya G . Choosing the appropriate side for subcutaneous port catheter placement in patients with mastectomy: ipsilateral or contralateral?. Radiol Med. 2017; 122(6):472-478. DOI: 10.1007/s11547-017-0736-8. View

Saugel B, Scheeren T, Teboul J . Ultrasound-guided central venous catheter placement: a structured review and recommendations for clinical practice. Crit Care. 2017; 21(1):225. PMC: 5572160. DOI: 10.1186/s13054-017-1814-y. View

10.

Isom C, Bream Jr P, Gallagher K, Walia S, Ahmed R, Kauffmann R . Placement of Subcutaneous Central Venous Ports in Breast Cancer Patients: Does Side Matter?. J Surg Res. 2019; 244:296-301. DOI: 10.1016/j.jss.2019.06.028. View

11.

Waks A, Winer E . Breast Cancer Treatment: A Review. JAMA. 2019; 321(3):288-300. DOI: 10.1001/jama.2018.19323. View

12.

Denduluri N, Chavez-MacGregor M, Telli M, Eisen A, Graff S, Hassett M . Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update. J Clin Oncol. 2018; 36(23):2433-2443. DOI: 10.1200/JCO.2018.78.8604. View

13.

Debourdeau P, Espie M, Chevret S, Gligorov J, Elias A, Dupre P . Incidence, risk factors, and outcomes of central venous catheter-related thromboembolism in breast cancer patients: the CAVECCAS study. Cancer Med. 2017; 6(11):2732-2744. PMC: 5673948. DOI: 10.1002/cam4.1201. View

14.

Akelma H, Salik F, Bicak M, Erdal Erbatur M . Local Anesthesia for Port Catheter Placement in Oncology Patients: An Alternative to Landmark Technique Using Ultrasound-Guided Superficial Cervical Plexus Block-A Prospective Randomized Study. J Oncol. 2019; 2019:2585748. PMC: 6699304. DOI: 10.1155/2019/2585748. View

15.

Keum D, Kim J, Chae M . Safety of a totally implantable central venous port system with percutaneous subclavian vein access. Korean J Thorac Cardiovasc Surg. 2013; 46(3):202-7. PMC: 3680606. DOI: 10.5090/kjtcs.2013.46.3.202. View

16.

Pu Y, Li Z, Zhi X, Shi Y, Meng A, Cheng F . Complications and Costs of Peripherally Inserted Central Venous Catheters Compared With Implantable Port Catheters for Cancer Patients: A Meta-analysis. Cancer Nurs. 2019; 43(6):455-467. DOI: 10.1097/NCC.0000000000000742. View

17.

Madabhavi I, Patel A, Sarkar M, Anand A, Panchal H, Parikh S . A Study of Use of "PORT" Catheter in Patients with Cancer: A Single-Center Experience. Clin Med Insights Oncol. 2017; 11:1179554917691031. PMC: 5395272. DOI: 10.1177/1179554917691031. View

18.

Madabhavi I, Patel A, Sarkar M, Kataria P, Kadakol N, Anand A . A study of the use of peripherally inserted central catheters in cancer patients: A single-center experience. J Vasc Nurs. 2018; 36(3):149-156. DOI: 10.1016/j.jvn.2018.05.001. View

19.

Chang D, Hiss S, Herich L, Becker I, Mammadov K, Franke M . Implantation of venous access devices under local anesthesia: patients' satisfaction with oral lorazepam. Patient Prefer Adherence. 2015; 9:943-9. PMC: 4501160. DOI: 10.2147/PPA.S80330. View

20.

Robinson A, Souied O, Bota A, LeVasseur N, Stober C, Hilton J . Optimal vascular access strategies for patients receiving chemotherapy for early-stage breast cancer: a systematic review. Breast Cancer Res Treat. 2018; 171(3):607-620. DOI: 10.1007/s10549-018-4868-x. View